VivoSeq
Other

TBI

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

TBI is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed4 · 67%
Not yet recruiting1 · 17%
Unknown status1 · 17%

Clinical Trials

Trial Activity

6 trials

Sodium Lactate in Severe TBI
Not yet recruiting·UUniversity of California, Los Angeles·Phase 2·NCT06701760·264 enrolled
mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms
Completed·UU.S. Army Medical Research and Development Command·Phase 2·NCT01611194·71 enrolled
Cold-stored Platelet Early Intervention in TBI
Completed·—·Phase 2·NCT04726410·100 enrolled
Risk of SDRs Under 3HP and 1HP Regimen for LTBI
Completed·NNational Taiwan University Hospital·Phase 3·NCT04094012·490 enrolled
Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects
Completed·GGlobal Alliance for TB Drug Development·Phase 1·NCT04865536·28 enrolled
IL-1ra Dose-range Study for Moderate-to-severe TBI Patients
Unknown status·—·Phase 2·NCT02997371·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)